Ellen Johansson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ellen Johansson has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Mikael Nilsson
Institute of Biomedicine, University of Gothenburg
16 shared publications - Carmen Moccia
Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden
14 shared publications - Elin Schoultz
Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden
13 shared publications - Shawn Liang
Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden
13 shared publications Elin Schoultz
Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
3 shared publicationsShawn Liang
Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
3 shared publications
Latest Publications
- Open Access
- 25 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Resolving thyroid lineage cell trajectories merging into a dual endocrine gland in mammals
The thyroid has a remarkable evolution, transforming from an exocrine constituent of the chordate endostyle to an endocrine gland in basal vertebrates. In mammals, a second endocrine cell type of presumed neural crest origin appears, although recent lineage tracing has firmly established thyroid C-cells are also endoderm-derived. Here, we characterize the global gene expression in both embryonic thyroid lineages at single-cell level and identify lineage-specific transcription factors and their network regulation of target genes implicated in thyroid development into a dual endocrine organ. Merging of the pharyngeal pouch-derived ultimobranchial bodies with the midline thyroid primordium is an ordered process featuring basement membrane dynamics and epithelial-mesenchymal plasticity required for precursor cells to disseminate and properly integrate, thus forming the typical histoarchitecture of thyroid follicles and parafollicular C-cells. Synchronous lineage growth of compound follicles is recapitulated in mixed-type thyroid carcinoma in which only the neuroendocrine tumor cells escape the follicle basement membrane boundaries and become invasive adopting a C-cell precursor-like migratory phenotype.
- 25 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessResolving thyroid lineage cell trajectories merging into a dual endocrine gland in mammals
The thyroid has a remarkable evolution, transforming from an exocrine constituent of the chordate endostyle to an endocrine gland in basal vertebrates. In mammals, a second endocrine cell type of presumed neural crest origin appears, although recent lineage tracing has firmly established thyroid C-cells are also endoderm-derived. Here, we characterize the global gene expression in both embryonic thyroid lineages at single-cell level and identify lineage-specific transcription factors and their network regulation of target genes implicated in thyroid development into a dual endocrine organ. Merging of the pharyngeal pouch-derived ultimobranchial bodies with the midline thyroid primordium is an ordered process featuring basement membrane dynamics and epithelial-mesenchymal plasticity required for precursor cells to disseminate and properly integrate, thus forming the typical histoarchitecture of thyroid follicles and parafollicular C-cells. Synchronous lineage growth of compound follicles is recapitulated in mixed-type thyroid carcinoma in which only the neuroendocrine tumor cells escape the follicle basement membrane boundaries and become invasive adopting a C-cell precursor-like migratory phenotype.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Movie 1 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Movie 1 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessMovie 1 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Movie 1 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
IF images Figure S1. Clonal tracing of sporadically developed BRAF mutant neoplasia in mouse thyroid.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
IF images Figure S1. Clonal tracing of sporadically developed BRAF mutant neoplasia in mouse thyroid.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
IF images Figure S2. Clonal tracing of BRAF mutant thyroid carcinoma that displays a follicular tumor phenotype.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
IF images Figure S2. Clonal tracing of BRAF mutant thyroid carcinoma that displays a follicular tumor phenotype.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Data from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Differentiated thyroid cancer primarily classified by tumor histology comprises follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC), which represent distinct malignancies regarding the pattern of tumor spreading, responsiveness to radioiodine treatment, and clinical outcome. As FTC and PTC also differ genetically i.e., RAS mutations predominate in FTC whereas mutant BRAF is much more frequent in PTC, it is assumed although yet unproven that the archetypical tumor growth pattern – follicular versus papillary – depends on mutation identity and potentially the graded signaling output of the MAPK pathway that differs in response to constitutive activation by RAS or BRAF. In this study, we show by clonal tracing in mice carrying a Braf mutant allele with targeted expression of BRAFV600E exclusively in the thyroid gland that sporadically developed tumors either adopt a follicular or a papillary phenotype depending on follicle origin. Moreover, a single tumor clone may transit from papillary to follicular growth associated with asymmetric distribution of stromal tissue in the immediate vicinity of the tumor. Key to these observations is monitoring the progeny of cells undergoing spontaneous recombination of both BrafCA and the reporter gene because of Cre leakage which, in contrast to after induced oncogene activation comprising all target cells, implies that tumors develop stochastically and asynchronously originating from a limited number of BRAF mutant cells and taking place within a preserved thyroid tissue microenvironment. The results suggest that the natural heterogeneity of follicles and tumor cell plasticity modify BRAFV600E-induced neoplastic growth leading to divergent tumor histogenesis.Significance:Cell-of-origin intrinsic features rather than driver mutation identity influence tumor growth patterning in differentiated thyroid cancer and might impact histopathologic diagnosis of thyroid carcinoma subtypes.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Differentiated thyroid cancer primarily classified by tumor histology comprises follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC), which represent distinct malignancies regarding the pattern of tumor spreading, responsiveness to radioiodine treatment, and clinical outcome. As FTC and PTC also differ genetically i.e., RAS mutations predominate in FTC whereas mutant BRAF is much more frequent in PTC, it is assumed although yet unproven that the archetypical tumor growth pattern – follicular versus papillary – depends on mutation identity and potentially the graded signaling output of the MAPK pathway that differs in response to constitutive activation by RAS or BRAF. In this study, we show by clonal tracing in mice carrying a Braf mutant allele with targeted expression of BRAFV600E exclusively in the thyroid gland that sporadically developed tumors either adopt a follicular or a papillary phenotype depending on follicle origin. Moreover, a single tumor clone may transit from papillary to follicular growth associated with asymmetric distribution of stromal tissue in the immediate vicinity of the tumor. Key to these observations is monitoring the progeny of cells undergoing spontaneous recombination of both BrafCA and the reporter gene because of Cre leakage which, in contrast to after induced oncogene activation comprising all target cells, implies that tumors develop stochastically and asynchronously originating from a limited number of BRAF mutant cells and taking place within a preserved thyroid tissue microenvironment. The results suggest that the natural heterogeneity of follicles and tumor cell plasticity modify BRAFV600E-induced neoplastic growth leading to divergent tumor histogenesis.Significance:Cell-of-origin intrinsic features rather than driver mutation identity influence tumor growth patterning in differentiated thyroid cancer and might impact histopathologic diagnosis of thyroid carcinoma subtypes.
- Open Access
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Figure 3 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Oligoclonal growth of BRAF-induced thyroid tumors revealed by clonal tracing. Images obtained from 6-month-old noninduced Tg-CreERT2;BrafCA/+;mTmG mice. Separate green (A′–D′) and red channels (A″–D″) are shown for clarity. A and B, Coordinated growth of contiguous mT+ and mG+ tumor clones. B–B″ show the high power of the boxed areas in A–A″. Indistinguishable growth patterns were noted except for minor mT+ (arrow) and mG+ (arrowheads) epithelial segments (outlined in B′ and B″ for comparison). C, Similar papillary growth patterns of adjoining mT+ and mG+ tumor clones. D, Dissimilar growth patterns of nearby but not connecting mT+ and mG+ tumor clones. Asterisks indicate cluster of neoplastic follicles. DAPI stained nuclei (in A–D). f, follicle; L, lumen. Bars: 100 (A, C, and D) μm.
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 3 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Oligoclonal growth of BRAF-induced thyroid tumors revealed by clonal tracing. Images obtained from 6-month-old noninduced Tg-CreERT2;BrafCA/+;mTmG mice. Separate green (A′–D′) and red channels (A″–D″) are shown for clarity. A and B, Coordinated growth of contiguous mT+ and mG+ tumor clones. B–B″ show the high power of the boxed areas in A–A″. Indistinguishable growth patterns were noted except for minor mT+ (arrow) and mG+ (arrowheads) epithelial segments (outlined in B′ and B″ for comparison). C, Similar papillary growth patterns of adjoining mT+ and mG+ tumor clones. D, Dissimilar growth patterns of nearby but not connecting mT+ and mG+ tumor clones. Asterisks indicate cluster of neoplastic follicles. DAPI stained nuclei (in A–D). f, follicle; L, lumen. Bars: 100 (A, C, and D) μm.
- Open Access
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
IF images Figure S1. Clonal tracing of sporadically developed BRAF mutant neoplasia in mouse thyroid.
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
IF images Figure S1. Clonal tracing of sporadically developed BRAF mutant neoplasia in mouse thyroid.
- Open Access
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Figure 2 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Clonal tracing of thyroid tumor development in noninduced Tg-CreERT2;BrafCA/+;mTmG mice. Reporter gene activation designated by switch from mTomato (mT+) to mGFP (mG+) expression was monitored by fluorescence microscopy. Induced Cre-mediated recombination served as controls for comparison. A and B, Normal thyroid tissue, overview (A) and high power (B), after tamoxifen treatment of control mice devoid of BrafCA. Arrows indicate scarce presence of mT+ cells escaping induced mTmG activation. C, Clusters of enlarged/neoplastic follicles exclusively containing mT+ (encircled) or mG+ cells in a Braf mutant mouse devoid of tamoxifen induction. Boxed areas are shown to the right for magnification. Arrowheads indicate single mG+ cells present in an adjacent normal follicle (asterisk). D and E, Widespread induction of mG+ thyroid cells in tamoxifen-injected mutant mice; representative image (D) and quantitation (n = 3; E). F and G, Escape from tamoxifen-induced reporter gene activation in neoplastic follicles and papillary tumor. Arrow (in F) indicates origin of tumor derived from a mT+ follicle; arrowheads indicate sparse mG+ activation among tumor cells. Colored arrows (in G) demarcate dual clonal origin of neoplastic follicle (encircled) distinguished by the presence or absence of reporter gene activation. H, Predicted labeling of tumor cell progeny depending on whether mTmG is stochastically activated before BrafCA activation (to the left) or hypothetically in cells in which BrafCA is already activated and the resulting downregulation of the Cre driver (the Tg promoter) prevents further Cre-mediated recombination, i.e., of the reporter gene (to the right). Bars: 500 (A and C), 100 (D and F) 50 (G), and 25 (B) μm.
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Clonal tracing of thyroid tumor development in noninduced Tg-CreERT2;BrafCA/+;mTmG mice. Reporter gene activation designated by switch from mTomato (mT+) to mGFP (mG+) expression was monitored by fluorescence microscopy. Induced Cre-mediated recombination served as controls for comparison. A and B, Normal thyroid tissue, overview (A) and high power (B), after tamoxifen treatment of control mice devoid of BrafCA. Arrows indicate scarce presence of mT+ cells escaping induced mTmG activation. C, Clusters of enlarged/neoplastic follicles exclusively containing mT+ (encircled) or mG+ cells in a Braf mutant mouse devoid of tamoxifen induction. Boxed areas are shown to the right for magnification. Arrowheads indicate single mG+ cells present in an adjacent normal follicle (asterisk). D and E, Widespread induction of mG+ thyroid cells in tamoxifen-injected mutant mice; representative image (D) and quantitation (n = 3; E). F and G, Escape from tamoxifen-induced reporter gene activation in neoplastic follicles and papillary tumor. Arrow (in F) indicates origin of tumor derived from a mT+ follicle; arrowheads indicate sparse mG+ activation among tumor cells. Colored arrows (in G) demarcate dual clonal origin of neoplastic follicle (encircled) distinguished by the presence or absence of reporter gene activation. H, Predicted labeling of tumor cell progeny depending on whether mTmG is stochastically activated before BrafCA activation (to the left) or hypothetically in cells in which BrafCA is already activated and the resulting downregulation of the Cre driver (the Tg promoter) prevents further Cre-mediated recombination, i.e., of the reporter gene (to the right). Bars: 500 (A and C), 100 (D and F) 50 (G), and 25 (B) μm.
- Open Access
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
IF images Figure S2. Clonal tracing of BRAF mutant thyroid carcinoma that displays a follicular tumor phenotype.
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
IF images Figure S2. Clonal tracing of BRAF mutant thyroid carcinoma that displays a follicular tumor phenotype.
- Open Access
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Figure 4 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Papillary–follicular transition in BrafCA-induced PTC. Advanced tumor stage of a 12-month-old noninduced Tg-CreERT2;BrafCA/+;mTmG mouse. Both thyroid lobes were serially sectioned from pole to pole for comprehensive evaluation. A–C, Overview of tumors present in the left thyroid lobe (encircled); transverse tissue section (A), 3D reconstruction (B), and schematic representation (C) of the predominant mT+ tumor clone (1) and associated mG+ clones (2–5). D–F, Distal/dorsal domain (D), proximal/ventral domain (E), and schematic representation (F) of mG+ clone 3. Arrows and arrowheads indicate outward evaginations and inward papillary formations, respectively, in consecutive segments of the same neoplastic epithelium of a giant follicle. Asterisks indicate follicular differentiation of emigrating mG+ tumor cells. Directions of continuity of clone 3 are indicated by green-colored arrows (in D and E). DAPI stained nuclei (in A, D and E). e, esophagus; t, trachea; s, stromal tissue of tumor. Bars: 500 (A) and 100 (D and E) μm.
- 7 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 4 from Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid Cancer
Papillary–follicular transition in BrafCA-induced PTC. Advanced tumor stage of a 12-month-old noninduced Tg-CreERT2;BrafCA/+;mTmG mouse. Both thyroid lobes were serially sectioned from pole to pole for comprehensive evaluation. A–C, Overview of tumors present in the left thyroid lobe (encircled); transverse tissue section (A), 3D reconstruction (B), and schematic representation (C) of the predominant mT+ tumor clone (1) and associated mG+ clones (2–5). D–F, Distal/dorsal domain (D), proximal/ventral domain (E), and schematic representation (F) of mG+ clone 3. Arrows and arrowheads indicate outward evaginations and inward papillary formations, respectively, in consecutive segments of the same neoplastic epithelium of a giant follicle. Asterisks indicate follicular differentiation of emigrating mG+ tumor cells. Directions of continuity of clone 3 are indicated by green-colored arrows (in D and E). DAPI stained nuclei (in A, D and E). e, esophagus; t, trachea; s, stromal tissue of tumor. Bars: 500 (A) and 100 (D and E) μm.